Literature DB >> 19223392

Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy.

Henriette Svarre Nielsen1, Rudi Steffensen, Kim Varming, Astrid G S Van Halteren, Eric Spierings, Lars P Ryder, Els Goulmy, Ole Bjarne Christiansen.   

Abstract

Healthy females, pregnant with a boy, generate immune responses against male-specific minor histocompatibility (HY) antigens. The clinical importance of these responses is evident in stem cell transplantation. Birth of a boy prior to a series of miscarriages reduces the chance of a subsequent live birth. This study explores the putative impact of known HY-presenting HLA alleles on future pregnancy outcome in women with at least three consecutive miscarriages following a birth [secondary recurrent miscarriage (SRM)]. HLA-A, -B, -DRB1, DRB3-5 and DQB1 genotyping was performed in 358 SRM patients and in 203 of their children born prior to the miscarriages. The subsequent live birth in women with boys prior to the miscarriages compared with girls is lower in women with HY-restricting HLA class II alleles [odds ratio (OR): 0.17 (0.1-0.4), P = 0.0001]. One HY-restricting HLA class II allele in women with firstborn boys significantly reduces the chances of a live birth [OR: 0.46 (0.2-0.9), P = 0.02]. Two HY-restricting HLA class II alleles further reduced this chance [OR: 0.21 (0.1-0.7), P = 0.02]. HY-restricting HLA class II did not reduce the chances of a live birth in SRM women with firstborn girls. HY-restricting HLA class II alleles are associated with a decreased chance of a live birth in SRM women with firstborn boys. These findings strongly indicate an aberrant maternal immune reaction against fetal HY-antigens in SRM. The results may shed light on the as-yet unknown immunological causes of SRM and may help understand the successful maternal acceptance of the fetal semi-allograft.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223392     DOI: 10.1093/hmg/ddp077

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

1.  Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Authors:  Olivia J Holland; Caitlin Linscheid; Herbert C Hodes; Traci L Nauser; Melissa Gilliam; Peter Stone; Larry W Chamley; Margaret G Petroff
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.

Authors:  Antoine L Perchellet; Susmita Jasti; Margaret G Petroff
Journal:  Biol Reprod       Date:  2013-10-31       Impact factor: 4.285

3.  Advances of intravenous immunoglobulin G in modulation of anti-fetal immunity in selected at-risk populations: science and therapeutics.

Authors:  O B Christiansen
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 4.  Clinical impact of H-Y alloimmunity.

Authors:  Rakesh Popli; Bita Sahaf; Hideki Nakasone; Joyce Yeuk Yu Lee; David B Miklos
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 5.  Review: Fetal antigens--identity, origins, and influences on the maternal immune system.

Authors:  M G Petroff
Journal:  Placenta       Date:  2011-01-05       Impact factor: 3.481

6.  H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.

Authors:  H S Nielsen; F Wu; Z Aghai; R Steffensen; A G van Halteren; E Spierings; O B Christiansen; D Miklos; E Goulmy
Journal:  Hum Reprod       Date:  2010-09-07       Impact factor: 6.918

7.  Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.

Authors:  Mary D Stephenson; William H Kutteh; Susan Purkiss; Cliff Librach; Patricia Schultz; Edwina Houlihan; Chuanhong Liao
Journal:  Hum Reprod       Date:  2010-07-15       Impact factor: 6.918

Review 8.  Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy.

Authors:  Caitlin Linscheid; Margaret G Petroff
Journal:  Am J Reprod Immunol       Date:  2013-02-08       Impact factor: 3.886

Review 9.  To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

Authors:  Elizabeth A Bonney; Stephen A Brown
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

Review 10.  New insights into mechanisms behind miscarriage.

Authors:  Elisabeth Clare Larsen; Ole Bjarne Christiansen; Astrid Marie Kolte; Nick Macklon
Journal:  BMC Med       Date:  2013-06-26       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.